We are excited to announce that Standard Bots has successfully raised $63 million in funding! This significant investment will allow us to further expand our operations and continue revolutionizing the field of collaborative robotics. Our advanced 6-axis robotic arms, proudly made in the USA, are setting new standards for payload capacity, ease of integration, and versatility across various applications. With cutting-edge vision features, our robots are being embraced by industries worldwide for their efficiency and reliability. This funding will support our efforts to enhance our manufacturing capabilities, invest in research and development, and bring even more innovative solutions to our customers. We are grateful for the confidence and support of our investors as we strive to lead the way in the robotics industry.
Standard Bots Secures $63 Million in Series B Funding for Revolutionary Robotic Arms Manufacturing in the USA
Recently funded 路 $63.0M Series bAutomation Machinery Manufacturing
Get the full Standard Bots company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
